NJ

AutoLenders and ALGO Recognized as 2022 Top Workplaces New Jersey by NJ.com and Jersey's Best

Retrieved on: 
Thursday, June 30, 2022

PHILADELPHIA, June 30, 2022 /PRNewswire/ -- Today, AutoLenders, New Jersey's #1 pre-owned car dealership for more than a decade, and ALGO, a wholly owned subsidiary of AutoLenders, announced that both companies have been named a New Jersey's Top Workplaces of 2022 by NJ.com and Jersey's Best. This award recognizes local businesses that prioritize employee-centered work culture and selects winners based entirely on anonymous, employee feedback.

Key Points: 
  • "Since AutoLenders' founding in 1979, we've been focused on fostering a connected, forward-thinking culture," said Mike Wimmer, AutoLenders Founder and CEO.
  • "That is why we are honored to be recognized as an NJ Top Workplaces 2022 winner for our continued emphasis on our employees.
  • This recognition comes on the heels of AutoLenders' first-ever fully integrated advertising campaign , that details just how transparent AutoLenders is.
  • For more information about AutoLenders and ALGO, visit www.autolenders.com and www.algonation.com or learn more on the AutoLenders YouTube channel.

NJ Top Doc, Dr. Paul Abend Continues To Receive Awards For His Work With Autism

Retrieved on: 
Friday, June 3, 2022

SCOTCH PLAINS, N.J., June 3, 2022 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved Paul Abend, DO for 2022. Dr. Paul Abend specializes in physical medicine, rehabilitation and pain medicine as a Physiatrist at the Sanãre Center for Integrative Medicine. Dr. Abend is double-board certified in Family Medicine and Physical Medicine and Rehabilitation.

Key Points: 
  • SCOTCH PLAINS, N.J., June 3, 2022 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved Paul Abend, DO for 2022.
  • Dr. Paul Abend specializes in physical medicine, rehabilitation and pain medicine as a Physiatrist at the Sanre Center for Integrative Medicine.
  • Recently, Dr. Abend received the Distinguished Alumni Award from his Medical School, Rowan Osteopathic Medical School for his work in Autism.
  • NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

New Fed Mortgage Partners with MTA Benefits to Bring Savings to Massachusetts Educators

Retrieved on: 
Tuesday, May 31, 2022

DANVERS, Mass., May 31, 2022 /PRNewswire-PRWeb/ -- Massachusetts-based New Fed Mortgage Corp., a multistate residential mortgage lender, is pleased to announce its recent partnership with MTA Benefits to offer a wide array of benefits to members of the Massachusetts Teachers Association (MTA) through an Affinity Program.

Key Points: 
  • DANVERS, Mass., May 31, 2022 /PRNewswire-PRWeb/ -- Massachusetts-based New Fed Mortgage Corp., a multistate residential mortgage lender, is pleased to announce its recent partnership with MTA Benefits to offer a wide array of benefits to members of the Massachusetts Teachers Association (MTA) through an Affinity Program.
  • "We are very excited to give a true benefit to the educators of Massachusetts," said Brian D'Amico, president of New Fed Mortgage.
  • New Fed Mortgage is nationally recognized company that was established locally in 2001.
  • New Fed Mortgage Corp. was founded in 2001 as a residential mortgage lender.

Global Impact, on Behalf of the Alliance for Advancing Health Online (AAHO), Shares Research and Announces Upcoming New Program at 75th World Health Assembly

Retrieved on: 
Wednesday, May 25, 2022

The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.

Key Points: 
  • The global research is intended to reveal insights on how to harness social media and online engagement to drive vaccine confidence.
  • Global Impact sought proposals that address how social media can be best utilized to better understand vaccine hesitancy and increase vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Blyncsy's Machine Vision Technology Selected to Improve Public Transit in New York Tri-State Area

Retrieved on: 
Tuesday, May 24, 2022

Port Authority of New York and New Jersey will also be piloting Payver to monitor paint line striping visibility and pavement condition.

Key Points: 
  • Port Authority of New York and New Jersey will also be piloting Payver to monitor paint line striping visibility and pavement condition.
  • Blyncsy's Payver technology utilizes dash cam imagery and machine learning algorithms to passively provide a roadway view of bus stops and automatically detect maintenance issues.
  • Blyncsy's machine vision technology can detect anything the eye can see, like whether a bus shelter is blocked or if trash and graffiti are present.
  • By using machine vision on roadways, agencies will gain near real-time insights, thus decreasing emissions and increasing the speed and efficiency of maintenance.

PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results

Retrieved on: 
Wednesday, May 11, 2022

2022 is shaping up to be an incredibly productive year for PDS Biotech, commented Dr. Frank Bedu-Addo, President and Chief Executive Officer of the Company.

Key Points: 
  • 2022 is shaping up to be an incredibly productive year for PDS Biotech, commented Dr. Frank Bedu-Addo, President and Chief Executive Officer of the Company.
  • Lastly, due to our partnering model and our financial discipline, we finished the quarter with a strong cash balance which we project to fund our current operations into 2024.
  • PDS Biotechs cash balance as of March 31, 2022 was approximately $58.9 million.
  • KEYTRUDA is a registered trademark of Merck Sharp and Dohme Corp. a subsidiary of Meck & Co., Inc. Kenilworth, NJ USA.

U.S. Army Educational Outreach Program Announces National Finalists, Regional Finalists, and State Winners in 20th Annual eCYBERMISSION Competition

Retrieved on: 
Monday, May 9, 2022

The U.S. Army Educational Outreach Program (AEOP) announced the National Finalists, along with Regional Finalists and State Winners, in the 20th annual eCYBERMISSION competition.

Key Points: 
  • The U.S. Army Educational Outreach Program (AEOP) announced the National Finalists, along with Regional Finalists and State Winners, in the 20th annual eCYBERMISSION competition.
  • eCYBERMISSION is an Army Educational Outreach Program (AEOP) competition administered by the National Science Teaching Association (NSTA).
  • The Regional Finalists, up to the top three per grade for each of the five regions, competed at the regional competition in April.
  • eCYBERMISSION is part of the Army Educational Outreach Program (AEOP) and administered by the National Science Teaching Association (NSTA).

Celldex Reports First Quarter 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, May 5, 2022

HAMPTON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

Key Points: 
  • HAMPTON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.
  • Celldex is currently completing enrollment in the Phase 1b multi-center, randomized, double-blind, placebo-controlled study of barzolvolimab in chronic spontaneous urticaria.
  • Data from this study (0.5, 1.5 and 3 mg/kg cohorts) have been submitted for a late breaking presentation at EAACI 2022.
  • Celldex remains on track to initiate Phase 2 studies in chronic spontaneous urticaria and chronic inducible urticaria (cold urticaria and symptomatic dermographism) in the second quarter of 2022.

PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology Annual Meeting

Retrieved on: 
Wednesday, April 27, 2022

This news follows the achievement of the enrollment objective of 30 patients in the CPI refractory arm announced in March.

Key Points: 
  • This news follows the achievement of the enrollment objective of 30 patients in the CPI refractory arm announced in March.
  • Abstract Title: Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.
  • The abstracts will be available on Thursday, May 26, 2022 at 5:00 PM EDT on ASCO.org .
  • We are excited about the opportunity to provide updates on two of our PDS0101 clinical programs at this years ASCO annual meeting, commented Dr. Lauren V. Wood, M.D., Chief Medical Officer at PDS Biotech.

Dr. Nicole Schrader Named As One of the Top-Three Vote-Getters in the Readers' Choice Awards

Retrieved on: 
Monday, April 25, 2022

PRINCETON, N.J., April 25, 2022 /PRNewswire-PRWeb/ -- Each year, Town Topics, Princeton's weekly community newspaper, encourages readers to vote for their favorite local businesses and services. In 2021, Town Topic readers voted to select their favorite plastic surgeon in Princeton. Dr. Nicole Schrader was named in the top three plastic surgeons by the community of Princeton, New Jersey. In the 2017 Readers' Choice Awards, Dr. Schrader was also recognized as one of the top plastic surgeons in Princeton. Interested individuals can view the results of the 2021 and 2017 Readers' Choice Awards at https://www.towntopics.com/wordpress/readers-choice-awards-results/.

Key Points: 
  • Dr. Nicole Schrader was named in the top three plastic surgeons by the community of Princeton, New Jersey.
  • In the 2017 Readers' Choice Awards, Dr. Schrader was also recognized as one of the top plastic surgeons in Princeton.
  • As a community-driven individual residing in Princeton, New Jersey, Dr. Nicole Schrader is proud to receive this award.
  • Dr. Schrader, the founder of Schrader Plastic Surgery, is a dual board-certified surgeon specializing in facial plastic , reconstructive surgery, otolaryngology, and head, neck surgery.